CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.

Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Tri-Union Seafoods, the manufacturer, voluntarily recalled specific lots "out of an abundance of caution." A defect to the ...

About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...

On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...

A major recall of canned tuna sold in dozens of states has been issued amid concerns that a packaging defect could ...

Shares of SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) climbed 2.7%, building on a previous gain of 2%, following the FDA ...

The head of a group of local exporters said they were getting ready to comply with the US government’s plan to require front-of-package nutrition labels on goods entering their country. Philippine ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

Study finds 11% of U.S. adults used dietary supplements for immune support pre-pandemic, emphasizing the importance of ...